Biosynth Carbosynth Overview

  • Founded
  • 1966
Founded
  • Status
  • Private
  • Employees
  • 114
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2
  • Investments
  • 3

Biosynth Carbosynth General Information

Description

Developer of drugs intended to serve diagnostic and pharmaceutical companies. The company specializes in carbohydrates, nucleosides, enzyme substrates, natural products and biochemicals for life science research and offers monosaccharides, oligosaccharides, polysaccharides, enzyme substrates, detergents and other related products, enabling clients to meet their diagnostic and pharmaceutical product needs.

Contact Information

Formerly Known As
Biosynth
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Axis House
  • High Street
  • Compton RG20 6NL
  • England, United Kingdom
+44 01635 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosynth Carbosynth Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosynth Carbosynth‘s full profile, request access.

Request a free trial

Biosynth Carbosynth Patents

Biosynth Carbosynth Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9127303-B2 Method for detection of beta-d-glucuronidase activity in a sample Active 08-Jun-2011 00000000
US-20140212905-A1 Novel method for detection of beta-d-glucuronidase Granted 08-Jun-2011 00000000 0
EP-2718458-B1 Novel method for detection of beta-d-glucuronidase Active 08-Jun-2011 00000000
EP-2718458-A1 Novel method for detection of beta-d-glucuronidase Granted 08-Jun-2011 00000000
EP-2532753-A1 Method for detection of beta-d-glucuronidase Ceased 08-Jun-2011 C12Q1/34 0
To view Biosynth Carbosynth’s complete patent history, request access »

Biosynth Carbosynth Executive Team (2)

Name Title Board Seat Contact Info
Philip Dawes Deputy Chief Financial Officer
Urs Spitz Co-Owner, Chief Executive Officer & President
To view Biosynth Carbosynth’s complete executive team members history, request access »

Biosynth Carbosynth Board Members (1)

Name Representing Role Since
000000 0000000000 Biosynth Carbosynth Board Member 000 0000
To view Biosynth Carbosynth’s complete board members history, request access »

Biosynth Carbosynth Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosynth Carbosynth Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biosynth Carbosynth‘s full profile, request access.

Request a free trial

Biosynth Carbosynth Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 17-Mar-2022 0000000000 Biotechnology 000 00000
0000000000 00 20-May-2019 0000000000 Distributors/Wholesale 000 00000
VaxYnethic 16-Mar-2016 Joint Venture Drug Discovery
To view Biosynth Carbosynth’s complete investments and acquisitions history, request access »

Biosynth Carbosynth Subsidiaries (1)

Company Name Industry Location Founded
00000000 Biotechnology Gardner, MA 0000
To view Biosynth Carbosynth’s complete subsidiaries history, request access »